Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP888307.RAWYBaX3oGKZo-SU3M0IL-FHau8dkHt1hadBUj7voCVYI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP888307.RAWYBaX3oGKZo-SU3M0IL-FHau8dkHt1hadBUj7voCVYI130_assertion type Assertion NP888307.RAWYBaX3oGKZo-SU3M0IL-FHau8dkHt1hadBUj7voCVYI130_head.
- NP888307.RAWYBaX3oGKZo-SU3M0IL-FHau8dkHt1hadBUj7voCVYI130_assertion description "[The results showed the frequency of the Asp299Gly genotype was increased in patients with chronic disease (OR 25.3, 95% CI 5.2-115.6, P�<�0.001) and patients with acute disease (OR 8.03, 95% CI 1.7-37.7, P�=�0.006) compared to LST negative subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888307.RAWYBaX3oGKZo-SU3M0IL-FHau8dkHt1hadBUj7voCVYI130_provenance.
- NP888307.RAWYBaX3oGKZo-SU3M0IL-FHau8dkHt1hadBUj7voCVYI130_assertion evidence source_evidence_literature NP888307.RAWYBaX3oGKZo-SU3M0IL-FHau8dkHt1hadBUj7voCVYI130_provenance.
- NP888307.RAWYBaX3oGKZo-SU3M0IL-FHau8dkHt1hadBUj7voCVYI130_assertion SIO_000772 21056683 NP888307.RAWYBaX3oGKZo-SU3M0IL-FHau8dkHt1hadBUj7voCVYI130_provenance.
- NP888307.RAWYBaX3oGKZo-SU3M0IL-FHau8dkHt1hadBUj7voCVYI130_assertion wasDerivedFrom befree-20140225 NP888307.RAWYBaX3oGKZo-SU3M0IL-FHau8dkHt1hadBUj7voCVYI130_provenance.
- NP888307.RAWYBaX3oGKZo-SU3M0IL-FHau8dkHt1hadBUj7voCVYI130_assertion wasGeneratedBy ECO_0000203 NP888307.RAWYBaX3oGKZo-SU3M0IL-FHau8dkHt1hadBUj7voCVYI130_provenance.